A new study from the Scripps Translational Science Institute, published in the American Journal of Medicine, shows that iRhythm's Zio patch, a wireless adhesive heart monitor patch, detects more ...

iRhythm Technologies, maker of the Zio patch peel-and-stick heart monitor, has raised $17 million in a round led by Novo A/S, a Danish life sciences investment firm. Previous investor Norwest Venture ...

SAN FRANCISCO, CA--(Marketwire - Mar 7, 2013) - iRhythm Technologies, Inc., a medical device, service and technology company that develops and markets simple, innovative diagnostic monitoring ...

Cardiac rhythm diagnostics device maker iRhythm Technologies has raised $17 million, according to a company statement, as providers try to keep patients out of the hospital, but keep an eye on warning ...

Wearables maker iRhythm Technologies on Tuesday released data suggesting its Zio patch increased rate of atrial fibrillation detection and reduced cardiac events, in results presented at the American ...

Read full article: ‘We just jumped out the window’: Children barely escape after truck slams into Oakland County living room Get ready for some fabulous deals for when you're on the go, your beauty ...

Sport fisherman Bob Hansen put's his heart and soul into the landing the big one. But last year, his heart began sending him a message back. "I felt like a little rumble inside my chest, kind of like ...

Biopharmas are looking to incorporate wearables when it comes to patient monitoring within clinical trials. Questions about how this data will or should be used still remain for regulators. But Gilead ...

The iRhythm Zio Patch was cleared by the FDA for use only by physician prescription using the 510(k) pathway as the product was deemed 'substantially equivalent' to predicate devices. We presented a ...

SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio ® long-term continuous ECG monitoring (LTCM) system, ...